Predominantly hemorrhagic choroidal neovascular lesion from exsudative age-related macular degeneration treated with intravitreal ranibizumab therapy / Lesão neovascular predominantemente hemorrágica da degeneração macular relacionada à idade, tratada com ranibizumab intravítrea
Rev. bras. oftalmol
; 72(3): 185-187, maio-jun. 2013. ilus
Article
in En
| LILACS
| ID: lil-690247
Responsible library:
BR1.2
ABSTRACT
The authors relate a predominantly hemorrhagic choroidal neovascular lesion from neovascular. Age-related macular degeneration patient case treated with intravitreal ranibizumab therapy. Monthly ranibizumab (six intravitreal injections) displayed a promising response but this limited report is insufficient to guarantee the indication for all predominantly hemorrhagic choroidal neovascular lesion from neovascular age-related macular degeneration. Further studies will be necessary for complete validation of our results for all predominantly hemorrhagic choroidal neovascular lesions from CNV due to AMD...
RESUMO
Os autores apresentam um caso de paciente com lesão neovascular predominantemente hemorrágica com degeneração macular relacionada à idade, tratada mensalmente com injenções intravítrea com ranibizumab. Discutem sua evolução, que apesar da boa resposta terapêutica, necessita de maiores estudos para confirmação de seus resultados...
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Choroidal Neovascularization
/
Intravitreal Injections
/
Immunologic Factors
/
Macular Degeneration
/
Antibodies, Monoclonal
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
Rev. bras. oftalmol
Journal subject:
OFTALMOLOGIA
Year:
2013
Document type:
Article
Affiliation country:
Brazil
/
United States
Country of publication:
Brazil